This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

'Fast Money' Recap: Apple Continues to Move Higher

Adami said the valuation for shares of Lockheed Martin (LMT) appears to be a little "stretched." He wouldn't buy the stock on the news that LMT was awarded a $915 million contract from the U.S. Air Force. 

Scaramucci pointed out that Lockheed Martin has very good management over its cash flow, paying investors a hefty dividend and buying back plenty of stock.

Najarian argued that shares of Broadcom (BRCM) appear poised to go north of $36 based on its low valuation. 

Adami said Google (GOOGL) looks likely to move back toward $600. Scaramucci is bullish on the stock over the long term. 

Must Read: 'Fast Money' Recap: Going Global

Seymour is not a buyer of Tesla Motors (TSLA) based on its valuation, future competition and current battery prices. 

Delta Air Lines (DAL) climbed 2% and was the first stock on the show's "Pops & Drops" segment. Scaramucci said he would own the stock as a trade into earnings. 

Teva Pharmaceutical Industries (TEVA) popped 3%. Seymour said he would stay long the stock as a play on emerging market healthcare. 

Take-Two Interactive Software (TTWO) fell 5%. Najarian pointed out the big short-interest in the stock, and reasoned that shares are simply selling off after a big run to the upside. 

ServiceNow (NOW) dropped 4%. Adami was not a buyer, based on valuation.

CNBC's Meg Tirrell was taking a look at Monday's movers from the American Society of Clinical Oncology (ASCO) conference. Ariad Pharmaceuticals (ARIA) climbed 7% on positive data related to its leukemia drug, Iclusig. Clovis Oncology (CLVS) fell 7% after it was revealed that a small number of patients had high blood sugar as a result of the company's lung cancer treatment. The CEO later insisted the treatment does "not cause diabetes."

Najarian said biotech stocks are always in the M&A scope from large-cap pharmaceutical companies looking for future growth. He is long Eli Lilly (LLY)

Adam Cecchetti, founder and chief research officer of Deja vu Securities, said hackers continue to find ways around securities systems that are in place, no matter how sophisticated they are. However, it's the devices that are connected to the Internet -- coffee makers, cars, home security/control systems -- that are the most vulnerable. His company specializes in securing these types of systems. 

For their final trades, Seymour is buying Deutsche Bank (DB) and Najarian is buying DAL. Scaramucci is a buyer of eBay (EBAY) and Adami is buying Marvell Technology Group (MRVL)

-- Written by Bret Kenwell in Petoskey, Mich.

Follow @BretKenwell

Follow on
Twitter and become a fan on Facebook.


Bret Kenwell currently writes, blogs and also contributes to Robert Weinstein's Weekly Options Newsletter.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $95.18 1.64%
FB $117.43 -0.96%
GOOG $692.36 -0.84%
TSLA $232.32 -3.92%
YHOO $36.01 -1.42%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs